Analyzing factors affecting pancreatic tumors and cysts
Official title: Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region
Run by Umeå University · NCT05155878 · Data updated 2026-11-12
This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | January 1, 2035 |
| Study ends | January 1, 2040 |
| Registry record updated | January 5, 2022 |
| Trial ID | NCT05155878 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients recommended for surgery due to tumors or cysts in the pancreas or periampullary region.
✕Probably not a fit
Patients who are not able to provide informed consent and are still alive at the study initiation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze prognostic and predictive factors related to the diagnosis and surgical treatment of cysts and tumors in the pancreas and periampullary region. Participants will be enrolled both prospectively and retrospectively, allowing for a comprehensive examination of clinical outcomes based on patient and tumor characteristics. The study will utilize clinical data along with blood and tissue samples to develop and validate biomarkers that could enhance treatment strategies.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment approaches for patients with pancreatic tumors and cysts.
How similar studies have gone: While similar studies have explored prognostic factors in pancreatic conditions, this specific approach focusing on biomarker development is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Recommended surgery for tumor or cyst in the pancreas or periampullary region * Information avalible in electronic journal files * Informed consent (or deceased for retrospective part of the study) Exclusion Criteria: * No informed consent (and still alive at study initiation)
Where it's running
-
Surgical Clinic at Umeå University Hospital
Umeå, Sweden Recruiting
Study contacts
- Principal investigator: Oskar Franklin, MD/PhD — University Hospital, Umeå
- Study coordinator: Oskar Franklin, MD/PhD
- Email: oskar.franklin@umu.se
- Phone: +4690785000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting pancreatic fistula after pancreaticoduodenectomy
This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.
-
Liquid biopsy biomarkers to detect and monitor pancreatic cancer
Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.
-
Registry collecting radiological data on pancreatic cancer
This study is collecting medical imaging data from patients with pancreatic cancer to see how their condition progresses and how well they respond to treatment.
-
Assessing survival and quality of life in patients with advanced pancreatic cancer
This study looks at how long people with advanced pancreatic cancer live and how their quality of life is affected while being treated at different hospitals in the Nordic region.
-
Tissue-glue injection into the pancreas during pancreaticoduodenectomy
This trial will test whether injecting a tissue glue called N-butyl-2-cyanoacrylate into the pancreatic remnant during pancreaticoduodenectomy reduces postoperative pancreatic fistulas in patients with a soft pancreas and a small main duct.
-
Tissue adhesive (Glubran®2) to reinforce pancreaticojejunostomy in soft pancreas
This trial will test whether adding a tissue adhesive glue (Glubran®2) to the pancreatic-jejunal connection reduces postoperative pancreatic leaks in adults with a soft pancreas undergoing pancreaticoduodenectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.